These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 20101093)

  • 1. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.
    Wang Y; Ait-Oufella H; Herbin O; Bonnin P; Ramkhelawon B; Taleb S; Huang J; Offenstadt G; Combadière C; Rénia L; Johnson JL; Tharaux PL; Tedgui A; Mallat Z
    J Clin Invest; 2010 Feb; 120(2):422-32. PubMed ID: 20101093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
    Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.
    Webb NR; De Beer MC; Wroblewski JM; Ji A; Bailey W; Shridas P; Charnigo RJ; Noffsinger VP; Witta J; Howatt DA; Balakrishnan A; Rateri DL; Daugherty A; De Beer FC
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1156-65. PubMed ID: 25745063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
    Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
    Kurobe H; Matsuoka Y; Hirata Y; Sugasawa N; Maxfield MW; Sata M; Kitagawa T
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1501-8. PubMed ID: 23535154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of TGF-β signaling in smooth muscle cell prevents elastase-induced abdominal aortic aneurysm.
    Gao F; Chambon P; Offermanns S; Tellides G; Kong W; Zhang X; Li W
    Biochem Biophys Res Commun; 2014 Nov; 454(1):137-43. PubMed ID: 25450370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-1 suppresses angiotensin II-induced aortic inflammation and aneurysm formation.
    Isoda K; Akita K; Kitamura K; Sato-Okabayashi Y; Kadoguchi T; Isobe S; Ohtomo F; Sano M; Shimada K; Iwakura Y; Daida H
    Int J Cardiol; 2018 Nov; 270():221-227. PubMed ID: 29884291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
    Ma H; Wang YL; Hei NH; Li JL; Cao XR; Dong B; Yan WJ
    J Mol Med (Berl); 2020 Apr; 98(4):541-551. PubMed ID: 32060588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.
    Liang ES; Bai WW; Wang H; Zhang JN; Zhang F; Ma Y; Jiang F; Yin M; Zhang MX; Chen XM; Qin WD
    Hypertension; 2018 Nov; 72(5):1189-1199. PubMed ID: 30354818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions.
    Chen X; Rateri DL; Howatt DA; Balakrishnan A; Moorleghen JJ; Cassis LA; Daugherty A
    PLoS One; 2016; 11(4):e0153811. PubMed ID: 27104863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model.
    Kurashiki T; Miyake T; Nakagami H; Nishimura M; Morishita R
    Hypertension; 2020 Dec; 76(6):1879-1888. PubMed ID: 33040618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic, Non-Canonical Role of Macrophage Elastase in Vascular Integrity.
    Salarian M; Ghim M; Toczek J; Han J; Weiss D; Spronck B; Ramachandra AB; Jung JJ; Kukreja G; Zhang J; Lakheram D; Kim SK; Humphrey JD; Sadeghi MM
    Circ Res; 2023 Feb; 132(4):432-448. PubMed ID: 36691905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses.
    Hwang JS; Kim HJ; Kim G; Kang ES; Ham SA; Yoo T; Paek KS; Yabe-Nishimura C; Kim HJ; Seo HG
    Int J Cardiol; 2014 Jun; 174(1):43-50. PubMed ID: 24698256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production.
    Giraud A; Zeboudj L; Vandestienne M; Joffre J; Esposito B; Potteaux S; Vilar J; Cabuzu D; Kluwe J; Seguier S; Tedgui A; Mallat Z; Lafont A; Ait-Oufella H
    Cardiovasc Res; 2017 Sep; 113(11):1364-1375. PubMed ID: 28582477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of Cathepsin S Suppresses Abdominal Aortic Aneurysm in Mice.
    Lai CH; Chang JY; Wang KC; Lee FT; Wu HL; Cheng TL
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):990-999. PubMed ID: 32033870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
    Lu HY; Huang CY; Shih CM; Chang WH; Tsai CS; Lin FY; Shih CC
    PLoS One; 2015; 10(4):e0121077. PubMed ID: 25876091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive EP4 Signaling in Smooth Muscle Cells Induces Abdominal Aortic Aneurysm by Amplifying Inflammation.
    Hiromi T; Yokoyama U; Kurotaki D; Mamun A; Ishiwata R; Ichikawa Y; Nishihara H; Umemura M; Fujita T; Yasuda S; Minami T; Goda M; Uchida K; Suzuki S; Takeuchi I; Masuda M; Breyer RM; Tamura T; Ishikawa Y
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1559-1573. PubMed ID: 32321307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan attenuates angiotensin II-induced abdominal aortic aneurysms through the inhibition of c-Jun N-terminal kinase and nuclear factor κB activation.
    Tsai SH; Wang JC; Liao WI; Hsu YJ; Lin CY; Liao MT; Huang PH; Lin SJ
    J Vasc Surg; 2018 Dec; 68(6S):72S-81S.e1. PubMed ID: 29290496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.